A61K 39/001196
Fusion proteins originating from gene translocation in cancer cells
Official title: {Fusion proteins originating from gene translocation in cancer cells}
A61K39/001196 (Fusion proteins originating from gene translocation in cancer cells) appears on 34 US grants and 90 published applications in this corpus.
Search patents in A61K- Granted patents
- 34
- Published applications
- 90
- Assignees
- 46
- Inventors
- 132
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 4 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 5 |
| 2010 | 0 | 2 |
| 2011 | 0 | 4 |
| 2012 | 0 | 2 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 6 |
| 2016 | 1 | 14 |
| 2017 | 2 | 7 |
| 2018 | 2 | 7 |
| 2019 | 1 | 2 |
| 2020 | 5 | 4 |
| 2021 | 5 | 6 |
| 2022 | 3 | 10 |
| 2023 | 1 | 7 |
| 2024 | 1 | 1 |
| 2025 | 3 | 3 |
| 2026 | 3 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods for increasing epithelial barrier function15 Sep 2026US 12,734,214 B2The Board of Trustees of the Leland Stanford Junior University
- Compositions and methods for metal containing formulations capable of modulating immune response12 May 2026US 12,622,922 B2The Regents of the University of Michigan
- T-cell receptor for treating fibrolamellar hepatocellular carcinoma20 Jan 2026US 12,528,853 B2St. Jude Children?S Research Hospital
- Compositions and methods for delivery of biomacromolecule agents10 Jun 2025US 12,324,843 B2The Regents of the University of Michigan
- Compositions for optimized BCR-ABL peptide vaccines6 May 2025US 12,290,554 B2Think Therapeutics, Inc.
- Detection of a genetic fusion or deletion that results in expression of a neoantigen2 Oct 2025US 2025/0302935 A1Flagship Pioneering Innovations VI, LLC
- Compositions and methods for delivery of biomacromolecule agents25 Sep 2025US 2025/0295805 A1The Regents of the University of Michigan
- Compositions for optimized bcr-abl peptide vaccines10 Jul 2025US 2025/0222087 A1Think Therapeutics, Inc.
- Compositions and methods for delivery of biomacromolecule agents11 Apr 2024US 2024/0115679 A1The Regents of the University of Michigan
- Mrna vaccine design using multiple interacting immuno-stimulatory pathways, for cancer and infectious diseases3 Aug 2023US 2023/0241193 A1MicroVAX, LLC
Most cited
By later US patents
- Compositions and methods for delivery of genetic material184US 5,739,118 AApollon Inc. · 1998
- Compositions and methods for delivery of genetic material132US 5,962,428 AApollon Inc. · 1999
- Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same90US 5,891,432 AThe Immune Response Corporation · 1999
- Compositions and methods for delivery of genetic material82US 5,981,505 AThe Trustees of the University of Pennsylvania · 1999
- Composition comprising a complexed (M)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof79US 9,572,874 B2CureVac AG · 2017